Neuer Versuch für Core One Labs Forum: Community User: Räuberhotzenplotzzz

Steigt ein bevor es zu spät ist 🚀👌🏼

Hallo Leute! Nun auch mal dabei. Synthetisches Psilocybin. Hört sich öhnlich gut an wie Amyris.

https://mobil.onvista.de/news/irw-news-core-one-labs-inc-core-one-labs-erzielt-durchbruch-bei-der-loesung-von-dosierungsproblemen-mit-psilocybin-durch-die-einbindung-von-biosynthetischem-psilocybin-in-seine-patentierte-duennfilm-verabreichungsmethode-426312391

🚀🚀🚀

Core One Labs Announces Breakthrough in Solving Psilocybin Dosing Problems by Introducing Biosynthetic Psilocybin to its Patented Thinstrip Delivery Method Vancouver, British Columbia, Canada – January 12, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce its plans to initiate another intellectual property strategy that will utilize its patented transmucosal thinstrip delivery method (“thinstrip delivery method”) in combination with its proprietary biosynthetic psilocybin, developed by its wholly-owned subsidiary, Vocan Biotechnologies Inc. (“Vocan”). The Company’s existing thinstrip delivery method has been patented for use with THC and CBD (CannaStripsTM) and has the potential for use with all naturally occurring compounds, including psilocybin Through cutting-edge research by the Company’s team at Vocan, a cost effective method for producing biosynthesized psilocybin has been developed. This low cost method of psilocybin production, in combination with the incorporation of psilocybin into the Company’s thinstrip technology, will result in an innovative and first-to-market delivery method of psilocybin for medical purposes. Core One’s objective in developing the psilocybin thinstrips is to assist with the delivery of revolutionary psychedelic treatment methods to address mental health conditions such as depression, anxiety and addictions. Methods of accurate dosing and effective delivery of psilocybin have gone relatively under-researched, and current methods utilized by companies using traditional oral delivery methods can cause hallucinations, digestive issues, and inaccurate dosages resulting in undesired side effects. The Company’s patented sublingual transmucosal (orally dissolvable) thinstrip technology, for the delivery of psilocybin, will aim to address these issues, and anticipates the provision of many potential advantages and benefits such as the rapid dissolving and onset of action to the bloodstream, as well as concentration control and *** released dosing. Thinstrip delivery technology is a natural, non-toxic, biodegradable, biocompatible composite, which is user friendly. The sublingual polymer thinstrip, with nano particulated active ingredients, skips the digestive system and is absorbed directly into the bloodstream through the membranes in the mouth, resulting in optimum bioavailability (absorption percentage) of the active ingredients. Direct delivery to the bloodstream means that dosages can be less potent with the same affect. According to the World Health Organization, almost 350 million people worldwide were affected by depression in 2016. Common antidepressant drugs help maintain the balance of various hormones and chemicals in the brain which assists in the treatment of depression. The Center for Disease Control and Prevention (CDC), reported that the percentage of people above the age of 12 years using antidepressants in the U.S. rose 12.7% in 2011-2014. According to MedGadget, the antidepressant drug market was valued at 13.69 billion in 2018 and is expected to reach 15.88 billion by 2025. The CDC said that in the U.S., antidepressants were the most commonly prescribed drugs in 2013 and from over 16 million long term users, around 70% are female. “One of the critical issues surrounding the use of psilocybin is accurate dosing in oral delivery methods. Our breakthrough technology is a game changer in the psychedelic space and has the potential to revolutionize the way patients receive psychedelics as medicine and reduce over concentrations and resulting adverse effects.” stated Dr. Robert E.W. Hancock, Executive Chairman of the Company.

Durch die neuen News

🚀

Der Anstieg kommt ziemlich sicher durch die erneute Werbung, die heute wieder gepusht wurde.

Ziemlich wenig los für „ Breaking News“

Breaking News gerade eben auf Boersennews

Ich denke mal, dass der Anstieg auf Biden zurückzuführen ist. Oder?

Gehypt durch den Artikel s.o. .

Warum der Anstieg heute ?

Danke für die Info, bin gespannt. Schwierig

Hallo zusammen bin neu hier bin heute mit einer großen Position eingestiegen versuche die Positionen langfristig zu halten

Philipp 500aktien